story of the week
Cardiovascular and Renal Outcomes With Efpeglenatide in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cardiovascular and Renal Outcomes With Efpeglenatide in Type 2 Diabetes
N. Engl. J. Med 2021 Jun 28;[EPub Ahead of Print], HC Gerstein, N Sattar, J Rosenstock, C Ramasundarahettige, R Pratley, RD Lopes, CSP Lam, NS Khurmi, L Heenan, S Del Prato, L Dyal, K Branch, AMPLITUDE-O Trial InvestigatorsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.